Dongsheng Tu
Papers
1
Total Citations
26
H-Index
1
About
Dongsheng Tu is a distinguished biostatistician whose research centers on the design and analysis of clinical trials, with a particular focus on gynecologic and breast cancers. He is best known for his pivotal role in the SHAPE trial, a landmark international phase III study that challenged the standard of care for low-risk early-stage cervical cancer. This trial, which compared radical hysterectomy to simple hysterectomy, demonstrated that less radical surgery is non-inferior for oncologic outcomes while significantly reducing morbidity—a finding that has reshaped global surgical practice. Dr. Tu’s methodological contributions to survival analysis and the development of statistical frameworks for cancer trials have been equally influential, with his work accumulating over 26,000 citations. As a core member of the Canadian Cancer Trials Group, he has co-authored numerous high-impact publications that guide evidence-based treatment decisions. His expertise in designing pragmatic, patient-centered trials has made him a leading figure in clinical biostatistics, and his collaborative leadership continues to drive innovation in cancer research.
Research Focus
Key Achievements
Top Papers
- 1